Abstract

BackgroundThe regeneration of articular hyaline cartilage remains an elusive goal despite years of research. Recently, an aragonite-hyaluronate (Ar-HA) biphasic scaffold has been described capable of cartilage regeneration over a 6-month follow-up period. This study was conducted in order to assess the fate of the regenerated osteochondral tissue in a 12-month-long validated caprine model.Hypothesis/purposeThe hypothesis was that the implantation of the Ar-HA implant leads to tissue regeneration and maturation.Study designA two-arm caprine model of a critical osteochondral defect compares the fate of acute osteochondral defects (group A) to Ar-HA implanted defects (group B).MethodsCritical 6 mm in diameter and 10-mm in depth osteochondral defects were created in the load-bearing medial femoral condyle of 20 mature goats and randomized into two groups. In group A (n = 6), a blood clot spontaneously filled the defect; in group B (n = 14), a single Ar-HA implant reconstructed the defect. The animals were sacrificed after either 6 or 12 months. Parameters assessed included clinical evaluation, x-rays, micro-CT, ultrasound and histology at both time points, and specimen high-field magnetic resonance imaging with T2 mapping at the 12-month time point.ResultsIn most group A animals, the defects were not reconstructed (1/3 at 6 months, and 0/3 at 12 months). Defects in group B were mostly reconstructed (5/7 at 6 months and 6/7 at 12 months). Group A defects were either empty or contained fibrous repair tissue; while group B filling was compatible with hyaline cartilage and normal bone.ConclusionAr-HA scaffolds implanted in critical osteochondral defects result in hyaline cartilage formation and subchondral bone regeneration. The results improved at the 12-month time point compared to the 6-month time point, indicating a continuous maturation process without deterioration of the repair tissue.Clinical relevanceOsteochondral defects are common in humans; the results of the current study suggest that an acellular Ar-HA scaffold might induce cartilage and subchondral bone regeneration.

Highlights

  • Group A defects were either empty or contained fibrous repair tissue; while group B filling was compatible with hyaline cartilage and normal bone

  • Clinical relevance: Osteochondral defects are common in humans; the results of the current study suggest that an acellular Ar-hyaluronic acid (HA) scaffold might induce cartilage and subchondral bone regeneration

  • Numerous surgical approaches have been proposed over the years to treat chondral or osteochondral lesions [1, 2], but native hyaline cartilage regeneration has not been achieved by any available treatment

Read more

Summary

Introduction

Numerous surgical approaches have been proposed over the years to treat chondral or osteochondral lesions [1, 2], but native hyaline cartilage regeneration has not been achieved by any available treatment. Two approaches to treat articular cartilage are feasible: exogenous-cell-based techniques or locally recruited stem-cell-based techniques. The optimal scaffold should allow bone repair in the subchondral area (a goal quite difficult to achieve as the bone tends to be a mixture of compact and woven bone [6]) and migration of mesenchymal stem cells and chondrocytes into the superficial cartilaginous layers, with new cartilage formation at the articular surface [6]. This study was conducted in order to assess the fate of the regenerated osteochondral tissue in a 12-month-long validated caprine model.

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call